Tumor
There is an ongoing discussion on safety aspects relating to the commercial whole-body electromyostimulation (WB-EMS) market. Apart …
@article{kemmlerResponseCommentaryRevisedContraindications2024,
author = {Wolfgang Kemmler and Michael Fröhlich and Oliver Ludwig and Christoph Eifler and Joshua Berger and Florian Micke and Heinz Kleinöder and Bernd Wegener and Christoph Zinner and Frank C Mooren and Marc Teschler and Andre Filipovic and S Müller and K England and Jens Vatter and Sebastian Authenrieth and Matthias Kohl and Simon von Thaden},
doi = {10.3389/fspor.2024.1473103},
editor = {Alessandra Di Cagno},
journal = {Frontiers in Sports and Active Living},
month = {10},
pages = {1473103},
publisher = {Frontiers Media SA},
title = {Response: Commentary: Revised contraindications for the use of non-medical WB-electromyostimulation. Evidence-based German consensus recommendations”},
volume = {6},
year = {2024}
}